These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10630844)

  • 1. Comment: risk of drug-disease and disease-drug interactions with anticonvulsants in HIV-positive patients.
    Jennings HR; Romanelli F
    Ann Pharmacother; 1999 Dec; 33(12):1373-4. PubMed ID: 10630844
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment: potential risk of valproic acid therapy in patients who are HIV-positive.
    Jennings HR; Romanelli F
    Ann Pharmacother; 2000 Nov; 34(11):1348-9. PubMed ID: 11098354
    [No Abstract]   [Full Text] [Related]  

  • 3. Serious erythromycin interactions caused by inhibition of drug metabolism in the liver.
    Wynn RL
    Gen Dent; 1996; 44(6):486-8, 490. PubMed ID: 9515389
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Birbeck et al.
    Wright E; Brew BJ; Lal L; Ali ST; Arayawichanont A; Imran D; Kamarulzaman A; Kongsaengdao S; Kruy L; Merati TP; Samintharapanya K; Sarim C; Tau G; Thangsing C; Vin-Samnang C; Wesselingh SL
    Epilepsia; 2008 Mar; 49(3):541-3. PubMed ID: 18302631
    [No Abstract]   [Full Text] [Related]  

  • 5. Protease inhibitors and anticonvulsants.
    Brooks J; Daily J; Schwamm L
    AIDS Clin Care; 1997 Nov; 9(11):87, 90. PubMed ID: 11364776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consultation-liaison psychiatry drug--drug interactions update.
    Armstrong SC; Cozza KL
    Psychosomatics; 2000; 41(6):541-3. PubMed ID: 11110122
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-drug interactions in HIV positive cancer patients.
    Flepisi BT; Bouic P; Sissolak G; Rosenkranz B
    Biomed Pharmacother; 2014 Jun; 68(5):665-77. PubMed ID: 24863536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test.
    Cheng CL; Smith DE; Carver PL; Cox SR; Watkins PB; Blake DS; Kauffman CA; Meyer KM; Amidon GL; Stetson PL
    Clin Pharmacol Ther; 1997 May; 61(5):531-43. PubMed ID: 9164415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate.
    Borin MT; Chambers JH; Carel BJ; Gagnon S; Freimuth WW
    Clin Pharmacol Ther; 1997 May; 61(5):544-53. PubMed ID: 9164416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant-induced chronic pancreatitis. A case report.
    Pezzilli R; Billi P; Melandri R; Broccoli PL; Fontana G
    Ital J Gastroenterol; 1992 Jun; 24(5):245-6. PubMed ID: 1623223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratogenicity of antiepileptic drugs: role of drug metabolism and pharmacogenomics.
    Sankar R
    Acta Neurol Scand; 2007 Jul; 116(1):65-71. PubMed ID: 17587258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticonvulsants and the monooxygenase system (review)].
    Saratikov AS; Novozheeva TP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(6):104-8. PubMed ID: 1664564
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of polypharmacy: prediction of drug interactions.
    Mather GG; Levy RH
    Epilepsy Res Suppl; 1996; 11():113-21. PubMed ID: 9294732
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.
    Bates DE; Herman RJ
    Ann Pharmacother; 2006 Jun; 40(6):1190-5. PubMed ID: 16720703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal medicine and epilepsy: proconvulsive effects and interactions with antiepileptic drugs.
    Samuels N; Finkelstein Y; Singer SR; Oberbaum M
    Epilepsia; 2008 Mar; 49(3):373-80. PubMed ID: 17941846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.
    Adedoyin A; Arns PA; Richards WO; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1998 Jul; 64(1):8-17. PubMed ID: 9695714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant drug interactions with antiepileptic drugs.
    Perucca E
    Br J Clin Pharmacol; 2006 Mar; 61(3):246-55. PubMed ID: 16487217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
    Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic enzymes and antiepileptic drug interactions.
    Levy RH; Mather GG
    Adv Neurol; 1998; 76():49-55. PubMed ID: 9408463
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interactions of antiepileptics].
    Opavský J
    Acta Univ Palacki Olomuc Fac Med; 1982; 102():289-97. PubMed ID: 6242582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.